Pro22-Leu199
19 kDa (Reducing)
Reconstitute at 0.1-1 mg/ml according to the size in ultrapure water after rapid centrifugation.
Exp Mol Med. 2020 Dec;52(12):1871-1878.
Cells. 2022 Jul 21;11(14):2257.
IL11 is a pro-inflammatory and pro-fibrotic member of the IL-6 family of cytokines that share commonality in the glycoprotein 130 (gp130) signaling receptor subunit, in combination with their cytokine-specific cognate receptors. This family of cytokines and their cognate receptors have been regarded as important contributors to cancer biology, and may serve as potential biomarkers in disease progression. IL-11 was considered (and is still thought) to be important for platelet function and to be cytoprotective, anti-inflammatory, and antifibrotic in organs, including the lung. However, advances made in the past few years using species-matched IL-11 in disease models in vitro and in vivo have begun to suggest an alternative role for IL-11. IL-11 signaling is now known to be centrally important for lung pathology and promotes a broad range of maladaptive effects, including lung epithelial cell dysfunction, stromal-driven inflammation, and myofibroblast activation.
Measured in a cell proliferation assay using TF-1 human erythroleukemic cells, the EC50 for this effect is less than 3ng/ml.
2μg (R: reducing condition, N: non-reducing condition).
>95% as determined by SEC-HPLC.